pharma · Pulmonary Arterial Hypertension (PAH)
AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals GmbH
AOP Orphan Pharmaceuticals trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Wien, AT HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- Wien, AT
- Programs
- 2
- Drugs
- 1
- Patents
- 7
AOP Orphan Pharmaceuticals clinical trials
Registry index of 2 ClinicalTrials.gov studies linked to AOP Orphan Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
AOP Orphan Pharmaceuticals trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for AOP Orphan Pharmaceuticals.
Trial registry
-
CTIS ↗ - 2025-523396-38-00CTIS ↗
LB-208, LB-208
Relapse or refractory (r/r) acute myeloid leukaemia (AML) and r/r higher-risk (HR) myelodysplastic syndrome (MDS)